{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:54:21Z","timestamp":1776329661804,"version":"3.50.1"},"reference-count":33,"publisher":"Baskent University","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.6002\/ect.2016.0335","type":"journal-issue","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T09:34:55Z","timestamp":1503567295000},"source":"Crossref","is-referenced-by-count":1,"title":[],"prefix":"10.6002","volume":"16","member":"4021","reference":[{"issue":"10","key":"ref0","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","unstructured":"1. Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093-2109.","journal-title":"Am J Transplant"},{"issue":"23","key":"ref1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","unstructured":"2. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730.","journal-title":"N Engl J Med"},{"issue":"6","key":"ref2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1399-0012.2007.00734.x","article-title":"Renal transplantation outcomes: a comparative analysis between elderly and younger recipients","volume":"21","author":"Mendon\u00e7a","year":"2007","unstructured":"3. Mendon\u00e7a HM, Dos Reis MA, de Castro de Cintra Sesso R, C\u00e2mara NO, Pacheco-Silva A. Renal transplantation outcomes: a comparative analysis between elderly and younger recipients. Clin Transplant. 2007;21(6):755-760.","journal-title":"Clin Transplant"},{"issue":"4","key":"ref3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/ndt\/16.4.824","article-title":"Renal transplantation in the elderly: a long-term, single-centre experience","volume":"16","author":"Saudan","year":"2001","unstructured":"4. Saudan P, Berney T, Leski M, Morel P, Bolle JF, Martin PY. Renal transplantation in the elderly: a long-term, single-centre experience. Nephrol Dial Transplant. 2001;16(4):824-828.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"ref4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2165\/00002512-200118100-00004","article-title":"Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive","volume":"18","author":"Meier-Kriesche HU","year":"2001","unstructured":"5. Meier-Kriesche HU, Kaplan B. Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive? Drugs Aging. 2001;18(10):751-759.","journal-title":"Drugs Aging"},{"issue":"8","key":"ref5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/01.tp.0000259621.56861.31","article-title":"Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients","volume":"83","author":"Rao","year":"2007","unstructured":"6. Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation. 2007;83(8):1069-1074.","journal-title":"Transplantation"},{"issue":"3","key":"ref6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.tp.0000275423.69689.dc","article-title":"Immunosuppression of the elderly kidney transplant recipient","volume":"84","author":"Danovitch","year":"2007","unstructured":"7. Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation. 2007;84(3):285-291.","journal-title":"Transplantation"},{"issue":"5","key":"ref7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1053\/j.ajkd.2012.08.049","article-title":"Kidney transplantation in the older adult","volume":"61","author":"Knoll","year":"2013","unstructured":"8. Knoll GA. Kidney transplantation in the older adult. Am J Kidney Dis. 2013;61(5):790-797.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"ref8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2165\/00002512-200016040-00004","article-title":"Immunosuppression in older renal transplant patients","volume":"16","author":"Morales","year":"2000","unstructured":"9. Morales JM, Campistol JM, Andr\u00e9s A, Herrero JC. Immunosuppression in older renal transplant patients. Drugs Aging. 2000;16(4):279-287.","journal-title":"Drugs Aging"},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1053\/j.ajkd.2008.04.018","article-title":"Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: a 1-year nonrandomized controlled trial","volume":"52","author":"Paoletti","year":"2008","unstructured":"10. Paoletti E, Amidone M, Cassottana P, Gherzi M, Marsano L, Cannella G. Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: a 1-year nonrandomized controlled trial. Am J Kidney Dis. 2008;52(2):324-330.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"ref10","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.transproceed.2010.07.007","article-title":"Regression of left ventricular hypertrophy in kidney transplant recipients: the potential role for inhibition of mammalian target of rapamycin.","volume":"42","author":"Paoletti","year":"2010","unstructured":"11. Paoletti E, Cannella G. Regression of left ventricular hypertrophy in kidney transplant recipients: the potential role for inhibition of mammalian target of rapamycin. Transplant Proc. 2010;42(9 Suppl):S41-43.","journal-title":"Transplant Proc","ISSN":"https:\/\/id.crossref.org\/issn\/0041-1345","issn-type":"print"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11255-008-9489-6","article-title":"Renal transplantation in the elderly","volume":"41","author":"Saxena","year":"2009","unstructured":"12. Saxena R, Yu X, Giraldo M, et al. Renal transplantation in the elderly. Int Urol Nephrol. 2009;41(1):195-210.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.intimp.2004.09.008","article-title":"Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients","volume":"5","author":"Ozaki","year":"2005","unstructured":"13. Ozaki KS, C\u00e2mara NO, Galante NZ, Camargo LF, Pacheco-Silva A. Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients. Int Immunopharmacol. 2005;5(1):103-106.","journal-title":"Int Immunopharmacol"},{"key":"ref13","volume-title":"The size of a clinical trial Clinical Trials","author":"Pocock","year":"1983","unstructured":"14. Pocock SJ. The size of a clinical trial. Clinical Trials: A Practical Approach. New York, NY: John Wiley & Sons Ltd; 1983."},{"issue":"9","key":"ref14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":"Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials","volume":"81","author":"Webster","year":"2006","unstructured":"15. Webster AC, Lee VW, Chapman JR, Craig JC. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation. 2006;81(9):1234-1248.","journal-title":"Transplantation"},{"issue":"5","key":"ref15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1399-3062.2010.00526.x","article-title":"Immunosuppressive therapy and infection after kidney transplantation","volume":"12","author":"Fortun","year":"2010","unstructured":"16. Fortun J, Martin-Davila P, Pascual J, et al. Immunosuppressive therapy and infection after kidney transplantation. Transpl Infect Dis. 2010;12(5):397-405.","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"ref16","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/TP.0b013e3182708e56","article-title":"Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis","volume":"94","author":"Andrassy","year":"2012","unstructured":"17. Andrassy J, Hoffmann VS, Rentsch M, et al. Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis. Transplantation. 2012;94(12):1208-1217.","journal-title":"Transplantation"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12882-015-0078-5","article-title":"mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis","volume":"16","author":"Xie","year":"2015","unstructured":"18. Xie X, Jiang Y, Lai X, Xiang S, Shou Z, Chen J. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. BMC Nephrol. 2015;16:91.","journal-title":"BMC Nephrol"},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/TP.0b013e318276a1ef","article-title":"Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8+ T-cell response compared with cyclosporine- or mycophenolate-treated patients","volume":"95","author":"Havenith","year":"2013","unstructured":"19. Havenith SH, Yong SL, van Donselaar-van der Pant KA, van Lier RA, ten Berge IJ, Bemelman FJ. Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8+ T-cell response compared with cyclosporine- or mycophenolate-treated patients. Transplantation; 2013;95(1):184-191.","journal-title":"Transplantation"},{"issue":"2","key":"ref19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/01.TP.0000164352.65613.24","article-title":"Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study","volume":"80","author":"Lorber","year":"2005","unstructured":"20. Lorber MI, Mulgaonkar S, Butt KM, et al. Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study. Transplantation. 2005;80(2):244-252.","journal-title":"Transplantation"},{"issue":"10","key":"ref20","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1111\/j.1600-6143.2005.01063.x","article-title":"Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients","volume":"5","author":"V\u00edtko","year":"2005","unstructured":"21. V\u00edtko S, Margreiter R, Weimar W, et al. Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am J Transplant. 2005;5(10):2521-2530.","journal-title":"Am J Transplant"},{"issue":"9","key":"ref21","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1681\/ASN.2011010006","article-title":"Randomized trial of immunosuppressive regimens in renal transplantation","volume":"22","author":"Guerra","year":"2011","unstructured":"22. Guerra G, Ciancio G, Gaynor JJ, et al. Randomized trial of immunosuppressive regimens in renal transplantation. J Am Soc Nephrol. 2011;22(9):1758-1768.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"ref22","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/j.1600-6143.2006.01340.x","article-title":"MMF","volume":"6","author":"Gallon","year":"2006","unstructured":"23. Gallon L, Perico N, Dimitrov BD, et al. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant. 2006;6(7):1617-1623.","journal-title":"Am J Transplant"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0012.2007.00756.x","article-title":"Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.","volume":"22","author":"Sampaio","year":"2008","unstructured":"24. Sampaio EL, Pinheiro-Machado PG, Garcia R, et al. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen. Clin Transplant. 2008;22(2):141-149.","journal-title":"Clin Transplant","ISSN":"https:\/\/id.crossref.org\/issn\/0902-0063","issn-type":"print"},{"issue":"3","key":"ref24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2215\/CJN.06940711","article-title":"Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus\/mycophenolate mofetil versus tacrolimus\/sirolimus","volume":"7","author":"Chhabra","year":"2012","unstructured":"25. Chhabra D, Skaro AI, Leventhal JR, et al. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus\/mycophenolate mofetil versus tacrolimus\/sirolimus. Clin J Am Soc Nephrol. 2012;7(3):504-512.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ctr.12156","article-title":"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients.","author":"Nashan","year":"2013","unstructured":"26. Nashan B. Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients. Clin Transplant. 2013;Suppl 25:16-29.","journal-title":"Clin Transplant","ISSN":"https:\/\/id.crossref.org\/issn\/0902-0063","issn-type":"print"},{"issue":"3","key":"ref26","doi-asserted-by":"publisher","first-page":"115S","DOI":"10.1016\/S0041-1345(03)00210-0","article-title":"Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients.","volume":"35","author":"Russ","year":"2003","unstructured":"27. Russ GR, Campbell S, Chadban S, et al. Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients. Transplant Proc. 2003;35(3 Suppl):115S-117S.","journal-title":"Transplant Proc","ISSN":"https:\/\/id.crossref.org\/issn\/0041-1345","issn-type":"print"},{"issue":"4","key":"ref27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.trre.2013.06.001","article-title":"Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation","volume":"27","author":"Peddi","year":"2013","unstructured":"28. Peddi VR, Wiseman A, Chavin K, Slakey D. Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation. Transplant Rev (Orlando). 2013;27(4):97-107.","journal-title":"Transplant Rev (Orlando)"},{"issue":"1","key":"ref28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.trim.2014.05.002","article-title":"Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes","volume":"31","author":"Shihab","year":"2014","unstructured":"29. Shihab F, Christians U, Smith L, Wellen JR, Kaplan B. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes. Transpl Immunol. 2014;31(1):22-32.","journal-title":"Transpl Immunol"},{"issue":"1","key":"ref29","first-page":"27","article-title":"Clinical evidence on the use of anti-mTOR drugs in renal transplantation.","volume":"31","author":"Hern\u00e1ndez","year":"2011","unstructured":"30. Hern\u00e1ndez D, Mart\u00ednez D, Guti\u00e9rrez E, et al. Clinical evidence on the use of anti-mTOR drugs in renal transplantation. Nefrologia. 2011;31(1):27-34.","journal-title":"Nefrologia","ISSN":"https:\/\/id.crossref.org\/issn\/0211-6995","issn-type":"print"},{"issue":"5","key":"ref30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1034\/j.1600-6143.2003.00094.x","article-title":"Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice","volume":"3","author":"Elloso","year":"2003","unstructured":"31. Elloso MM, Azrolan N, Sehgal SN, et al. Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice. Am J Transplant. 2003;3(5):562-569.","journal-title":"Am J Transplant"},{"issue":"1","key":"ref31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2007.09.019","article-title":"Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-\/- mice despite severe hypercholesterolemia","volume":"198","author":"Mueller","year":"2008","unstructured":"32. Mueller MA, Beutner F, Teupser D, Ceglarek U, Thiery J. Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-\/- mice despite severe hypercholesterolemia. Atherosclerosis. 2008;198(1):39-48.","journal-title":"Atherosclerosis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"iii14","DOI":"10.1093\/ndt\/gfl296","article-title":"Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients.","volume":"21","author":"Andr\u00e9s","year":"2006","unstructured":"33. Andr\u00e9s V, Castro C, Campistol JM. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients. Nephrol Dial Transplant. 2006;21 Suppl 3:iii14-7.","journal-title":"Nephrol Dial Transplant","ISSN":"https:\/\/id.crossref.org\/issn\/0931-0509","issn-type":"print"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T09:17:38Z","timestamp":1719393458000},"score":1,"resource":{"primary":{"URL":"http:\/\/ectrx.org\/forms\/ectrxcontentshow.php?doi_id=10.6002\/ect.2016.0335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2016.0335","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}